cilostazol has been researched along with Hypertension, Pulmonary in 4 studies
Hypertension, Pulmonary: Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cilostazol is a PDE3 inhibitor and used to treat peripheral arterial disease." | 1.39 | The effect of cilostazol on right heart function and pulmonary pressure. ( Akgun, T; Alici, G; Alizade, E; Demir, S; Emiroglu, Y; Ozkan, B; Pala, S; Sahin, M; Turkmen, MM; Yazicioglu, MV, 2013) |
| "Cilostazol was given to group 2 orally on days 28-90." | 1.35 | Cilostazol therapy attenuates monocrotaline-induced pulmonary arterial hypertension in rat model. ( Chang, LT; Chiang, CH; Lee, FY; Sheu, JJ; Sun, CK; Wu, CJ; Yip, HK; Youssef, AA, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, T | 1 |
| Zhang, E | 1 |
| Omori, A | 1 |
| Kabwe, J | 1 |
| Kawai, M | 1 |
| Maruyama, J | 1 |
| Okada, A | 1 |
| Yokochi, A | 1 |
| Sawada, H | 1 |
| Mitani, Y | 1 |
| Maruyama, K | 1 |
| Sahin, M | 1 |
| Alizade, E | 1 |
| Pala, S | 1 |
| Alici, G | 1 |
| Ozkan, B | 1 |
| Akgun, T | 1 |
| Emiroglu, Y | 1 |
| Demir, S | 1 |
| Yazicioglu, MV | 1 |
| Turkmen, MM | 1 |
| Sun, CK | 2 |
| Lee, FY | 2 |
| Sheu, JJ | 2 |
| Yuen, CM | 1 |
| Chua, S | 1 |
| Chung, SY | 1 |
| Chai, HT | 1 |
| Chen, YT | 1 |
| Kao, YH | 1 |
| Chang, LT | 2 |
| Yip, HK | 2 |
| Chiang, CH | 1 |
| Youssef, AA | 1 |
| Wu, CJ | 1 |
4 other studies available for cilostazol and Hypertension, Pulmonary
| Article | Year |
|---|---|
Model difference in the effect of cilostazol on the development of experimental pulmonary hypertension in rats.
Topics: Animals; Biomarkers; Cilostazol; Hypertension, Pulmonary; Male; Phosphodiesterase 3 Inhibitors; Prot | 2021 |
The effect of cilostazol on right heart function and pulmonary pressure.
Topics: Aged; Cilostazol; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; | 2013 |
Early combined treatment with cilostazol and bone marrow-derived endothelial progenitor cells markedly attenuates pulmonary arterial hypertension in rats.
Topics: Animals; Bone Marrow Transplantation; Cilostazol; Combined Modality Therapy; Endothelial Cells; Fluo | 2009 |
Cilostazol therapy attenuates monocrotaline-induced pulmonary arterial hypertension in rat model.
Topics: Animals; Blood Pressure; Body Weight; Cilostazol; Connexin 43; Disease Models, Animal; Endothelium, | 2008 |